Oncobiologics' Series A - III Round

Oncobiologics raised a round of funding on December 23, 2015.

Oncobiologics is a privately-held biopharmaceutical company focused on developing and commercializing monoclonal antibody biosimilar therapeutics. It is advancing its pipeline of 11 biosimilar product…

Articles about Oncobiologics' Series A - III Round: